Display options
Cite
Del Rosso JQ. Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. J Clin Aesthet Dermatol. 2015;8(5):19-26
Del Rosso, J. Q. (2015). Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. The Journal of clinical and aesthetic dermatology, 8(5), 19-26.
Del Rosso, James Q. "Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation." The Journal of clinical and aesthetic dermatology vol. 8,5 (2015): 19-26.
Del Rosso JQ. Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. J Clin Aesthet Dermatol. 2015 May;8(5):19-26. PMID: 26029331; PMCID: PMC4445892.
Copy Download .nbib Format: NLM
Share it on

J Clin Aesthet Dermatol. 2015 May;8(5):19-26.

Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation.

The Journal of clinical and aesthetic dermatology

James Q Del Rosso

Affiliations

  1. Touro University College of Osteopathic Medicine, Henderson, Nevada; Las Vegas Dermatology, Las Vegas, Nevada; Las Vegas Dermatology Research Center, Las Vegas, Nevada.

PMID: 26029331 PMCID: PMC4445892

Abstract

Oral antibiotics have been used for the treatment of acne vulgaris for six decades. Among dermatologists, tetracyclines represent at least three-fourths of the oral antibiotics prescribed in clinical practice. Unlike other specialties, antibiotic use in dermatology is predominantly for the treatment of noninfectious disorders, such as acne vulgaris and rosacea, which usually involves prolonged therapy over several weeks to months as compared to short courses used to treat cutaneous infections. At the present time, doxycycline and minocycline are the most commonly prescribed tetracyclines in dermatology, used primarily for treatment of acne vulgaris with a long overall favorable track record of effectiveness and safety. Although both are commonly used, doxycycline may be chosen by clinicians more readily as there is a lower risk of rare yet potentially serious adverse reactions, although doxycycline does warrant preventative measures to reduce the risks of esophagitis and phototoxicity reactions. This article reviews data with a new double-scored small 150mg tablet of doxycycline hyclate that has proven functional scoring, exhibits bioavailability similar to enteric-coated doxycycline, and has been shown to be associated with a low potential for gastrointestinal adverse reactions very comparable to what is achieved with enteric-coated tablets.

References

  1. Cutis. 2000 Oct;66(4 Suppl):7-13 - PubMed
  2. Semin Cutan Med Surg. 2001 Sep;20(3):139-43 - PubMed
  3. Br J Dermatol. 2003 Mar;148(3):467-78 - PubMed
  4. J Am Acad Dermatol. 2003 Jul;49(1 Suppl):S1-37 - PubMed
  5. Am J Clin Dermatol. 2003;4(12):813-31 - PubMed
  6. Cutis. 2004 Aug;74(2):118-22 - PubMed
  7. Expert Opin Pharmacother. 2005 Mar;6(3):409-18 - PubMed
  8. Clin Ther. 2005 Sep;27(9):1329-42 - PubMed
  9. J Am Acad Dermatol. 2006 Feb;54(2):258-65 - PubMed
  10. J Am Acad Dermatol. 2007 Apr;56(4):651-63 - PubMed
  11. J Am Acad Dermatol. 2007 May;56(5):791-802 - PubMed
  12. Cutis. 2006 Oct;78(4 Suppl):11-20 - PubMed
  13. Cutis. 2007 Jun;79(6 Suppl):9-25 - PubMed
  14. Br J Dermatol. 2008 Feb;158(2):208-16 - PubMed
  15. Dermatol Clin. 2009 Jan;27(1):33-42 - PubMed
  16. Arch Dermatol. 2009 Jan;145(1):63-6 - PubMed
  17. J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50 - PubMed
  18. J Am Acad Dermatol. 2010 Feb;62(2):315-8 - PubMed
  19. Am J Gastroenterol. 1991 Jun;86(6):748-50 - PubMed
  20. Am J Clin Dermatol. 2010;11(5):327-41 - PubMed
  21. J Drugs Dermatol. 2010 Nov;9(11):1407-11 - PubMed
  22. J Clin Aesthet Dermatol. 2011 Feb;4(2):40-7 - PubMed
  23. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002086 - PubMed
  24. Pediatrics. 2013 May;131 Suppl 3:S163-86 - PubMed
  25. J Pharm Pharmacol. 2014 Jan;66(1):32-9 - PubMed
  26. J Manag Care Spec Pharm. 2015 Jan;21(1):76-86 - PubMed
  27. Clin Drug Investig. 1995 Dec;10(6):323-7 - PubMed
  28. Arch Dermatol. 1985 May;121(5):618-23 - PubMed
  29. J Clin Pharmacol. 1988 Apr;28(4):367-70 - PubMed
  30. J Am Acad Dermatol. 1985 Feb;12(2 Pt 1):308-12 - PubMed
  31. JAMA. 1985 Feb 15;253(7):1009-11 - PubMed
  32. Arch Dermatol. 1972 May;105(5):681-3 - PubMed
  33. Clin Exp Dermatol. 1993 Sep;18(5):425-7 - PubMed
  34. Br J Dermatol. 1996 Apr;134(4):693-5 - PubMed
  35. Arch Dermatol. 1997 Oct;133(10):1224-30 - PubMed

Publication Types